[HTML] cell.comFull View

[HTML][HTML] PROTACs: an emerging therapeutic modality in precision medicine

DA Nalawansha, CM Crews - Cell chemical biology, 2020 - cell.com
Targeted protein degradation (TPD) has emerged as an exciting new era in chemical
biology and drug discovery. PROteolysis TArgeting Chimera (PROTAC) technology targets …
被引用次数：305 相关文章

PROTACs: An Emerging Therapeutic Modality in Precision Medicine

DA Nalawansha, CM Crews - Cell chemical biology, 2020 - pubmed.ncbi.nlm.nih.gov
Targeted protein degradation (TPD) has emerged as an exciting new era in chemical
biology and drug discovery. PROteolysis TArgeting Chimera (PROTAC) technology targets …
[HTML] sciencedirect.com

[HTML][HTML] PROTACs: An Emerging Therapeutic Modality in Precision Medicine

DA Nalawansha, CM Crews - Cell Chemical Biology, 2020 - Elsevier
Targeted protein degradation (TPD) has emerged as an exciting new era in chemical
biology and drug discovery. PROteolysis TArgeting Chimera (PROTAC) technology targets …
[HTML] nih.gov

[HTML][HTML] PROTACs: An Emerging Therapeutic Modality in Precision Medicine

DA Nalawansha, CM Crews - Cell chemical biology, 2020 - ncbi.nlm.nih.gov
Abstract Targeted Protein Degradation (TPD) has emerged as an exciting new era in
chemical biology and drug discovery. PROteolysis TArgeting Chimera (PROTAC) …

[引用][C] PROTACs: An Emerging Therapeutic Modality in Precision Medicine

DA Nalawansha, CM Crews - Cell Chemical Biology, 2020 - cir.nii.ac.jp
PROTACs: An Emerging Therapeutic Modality in Precision Medicine | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …

PROTACs: An Emerging Therapeutic Modality in Precision Medicine.

DA Nalawansha, CM Crews - Cell Chemical Biology, 2020 - europepmc.org
Abstract Targeted Protein Degradation (TPD) has emerged as an exciting new era in
chemical biology and drug discovery. PROteolysis TArgeting Chimera (PROTAC) …